Cargando…
EZH2: a novel target for cancer treatment
Enhancer of zeste homolog 2 (EZH2) is enzymatic catalytic subunit of polycomb repressive complex 2 (PRC2) that can alter downstream target genes expression by trimethylation of Lys-27 in histone 3 (H3K27me3). EZH2 could also regulate gene expression in ways besides H3K27me3. Functions of EZH2 in cel...
Autores principales: | Duan, Ran, Du, Wenfang, Guo, Weijian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7385862/ https://www.ncbi.nlm.nih.gov/pubmed/32723346 http://dx.doi.org/10.1186/s13045-020-00937-8 |
Ejemplares similares
-
EZH2: novel therapeutic target for human cancer
por: Li, Long-Yuan
Publicado: (2014) -
Epigenetic regulation of cancer progression by EZH2: from biological insights to therapeutic potential
por: Gan, Lu, et al.
Publicado: (2018) -
Targeted Disruption of the EZH2/EED Complex Inhibits EZH2-dependent Cancer
por: Kim, Woojin, et al.
Publicado: (2013) -
EZH2 in Bladder Cancer, a Promising Therapeutic Target
por: Martínez-Fernández, Mónica, et al.
Publicado: (2015) -
The role of EZH1 and EZH2 in development and cancer
por: Lee, Soo Hyun, et al.
Publicado: (2022)